Desloratadine in combination with montelukast in the treatment of chronic urticaria: A randomized, double-blind, placebo-controlled study

Clinical and Experimental Allergy

Volumn 34, Issue 9, 2004, Pages 1401-1407

  Nettis, E ^a,b   Colanardi, M C ^a   Paradiso, M T ^a   Ferrannini, A ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Chronic urticaria; Desloratadine; Montelukast; Placebo controlled

Indexed keywords

DESLORATADINE; MONTELUKAST; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC URTICARIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; URTICARIA;

ACETATES; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LEUKOTRIENE ANTAGONISTS; LORATADINE; MALE; MIDDLE AGED; PRURITUS; QUALITY OF LIFE; QUINOLINES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URTICARIA;

EID: 4544236522     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02019.x     Document Type: Article

References (27)

1. Sabroe RA, Greaves MW. The pathogenesis of chronic idiopathic urticaria. Arch Dermatol 1997; 133:1003-8.
2. Champion RH. Urticaria: then and now. Br J Dermatol 1988; 119:427-36.
3. Greaves MW. Chronic urticaria. N Engl J Med 1995; 332:1767-72.
4. Greaves MW. Chronic urticaria. J Allergy Clin Immunol 2000; 105:664-72.
5. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136:197-201.
6. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210-16.
7. Geha RS, Meltzer EO. Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol 2001; 107:751-62.
8. Ring J, Hein R, Gauger A et al. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. Int J Dermatol 2001; 40:72-6.
9. Schwartz LB. Mast cells and their role in urticaria. J Am Acad Dermatol 1991; 25:190-204.
10. Maxwell DL, Atkinson BA, Spur BW, Lessof MH, Lee TH. Skin responses to intradermal histamine and leukotrienes C4, D4 and E4 in Patients with chronic urticaria and in normal subjects. J Allergy Clin Immunol 1990; 86:759-65.
11. Chu TJ, Warren MS. Zafirlukast in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1998; 101:155.
12. Ellis M. Successful treatment of chronic urticaria with leukotrienes antagonist. J Allergy Clin Immunol 1998; 102:876-7.
13. Nettis E, Dambra P, D'Oronzio L, Loria MP, Ferrannini A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol 2001; 137:99-100.
14. Reimers A, Picler C, Helbling A, Pichler WJ, Yawalkar N. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 2002; 32:1763-8.
15. Nettis E, Pannofino A, Cavallo E, Ferrannini A, Tursi A. Efficacy of Montelukast, in combination with Loratadine, in the treatment of delayed pressure urticaria. J Allergy Clin Immunol 2003; 112:212-3.
16. Sabroe RA, Seed PT, Stat C et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999; 40:443-50.
17. Nettis E, Dambra P, D'Oronzio L et al. Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol 2002; 27:29-31.
18. Reicin A, White R, Weinstein SF et al. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 2000; 160:2481-8.
19. Meltzer EO, Malmstrom K, Lu S et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomised, placebo-controlled clinical trial. J Allergy Clin Immunol 2000; 105:917-22.
20. Wilson AM, Orr LC, Sims EJ, Lipworth BJ. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001; 31:61-8.
21. Asero R. Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria. Ann Allergy Asthma Immunol 2000; 85:156-7.
22. Hani N, Hartmann K, Casper C et al. Improvement of cold urticaria by treatment with leukotriene receptor antagonist montelukast. Acta Derm Venereol 2000; 80:229.
23. Berkun Y, Shalit M. Successful treatment of delayed pressure urticaria with montelukast. Allergy 2000; 55:203-4.
24. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopatic urticaria: A single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002; 110:484-8.
25. Asero R, Tedeschi A, Lorini M. Leukotriene receptor antagonist in chronic urticaria. Allergy 2001; 56:456-7.
26. Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acerylsalicylic acid. Clin Exp Allergy 2001; 31:1607-14.
27. Norris GJ, Sullivan TJ. Leukotrienes and cytokines in steroid dependent urticaria. J Allergy Clin Immunol 1998; 101:128.